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The following considerations prompted us to
investigate the effect of thyroid hormone on the
hair cycle, as well as on the chemical induction of
epidermal tumors in mice.
(a) It has been found by us (1—4) and con-
firmed by others (5) that under certain experi-
mental conditions cortisone administration stim-
ulates the chemical induction of epidermal tumors
in mice. The higher tumor incidence was shown
to be largely due to the steroid's inhibitory in-
fluence on the hair follicular activity in these
animals (6—11).
Several investigators agree that carcinogenic
exposure during hair follicular rest (telogen)
causes tumors to develop in a greater number of
animals than does exposure which is enacted
during hair follicular growth (anagen) (12—14).
This "hair cycle effect," therefore, cannot be
ignored in any study of epidermal tumor produc-
tion by agents capable of affecting hair growth.
(b) Experimental evidence is on hand that
thyroid hormone can alter the hair cycle in a
direction opposite to the effect of cortisone
(7, 15—18): whereas cortisone was shown to cause
inhibition of hair growth, thyroid hormone was
shown to cause stimulation.
In 1926, Chang reported that thyroidectomy
results in a reduction of hair growth in rats (15).
According to Baker, this effect of thyroid removal
includes both slowed down regrowth of hair
after clipping and progressive retardation of the
onset of subsequent pelages (7). Butcher induced
hair follicular activity in underfed rats by the
injection of thyroxin (16, 17).
In Mohn's rat experiments, natural hair
growth and spreading of the growth wave over
the body surface were accelerated by thyroxin
and the intervals between consecutive pelages
were shortened (no influence of thyroxin on
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hair growth was apparent after plucking of the
hair (18)).
(c) Literature reports regarding the influence
of thyroid hormone on spontaneous or experi-
mental tumor growth seem to lack conformity.
According to Grad, Berenson, and Caplan, the
incidence of "spontaneous lymphatic leukemia"
in mice was significantly reduced in response to
thyroxin and higher in mice rendered "hypo-
thyroid" by thiouracil administration (19); the
thyroxin effect, however, did not occur when the
weight loss caused by thyroxin was prevented
adequately.
Also Franks, Bather, and Thomson observed an
inhibitory influence of thyroxin on the develop-
ment of tumors in mice painted with methyicho-
lanthrene or injected with dimethylbenzanthra-
cene, whereas thiouracil appeared to produce an
effect in the opposite direction (20, 21).
Regarding a possible role of thyroid hormone
in human cancer, Pelner proposed that the hor-
mone reduces the incidence, because (1) genital
and mammary cancer were more frequently ob-
served after thyroidectomy, (2) because high
goiter- and cancer rates were found to coincide
in certain geographic areas, and (3) because a
positive correlation was noted between decreased
thyroid function and increased cancer incidence
in old age (22). A similar parallelism of high goiter-
and cancer incidence was observed by Spencer
(23), as well as by Stocks (24).
On the other hand, Shibata—in 1929—was able
to prevent epithelial proliferation on coal tar
painted rabbit ears by partial thyroidectomy
(25); and Levine and Kugel (in 1933) demonstrated
poorer growth of implanted tumors in thyroidect-
omized mice than in controls (26), a finding which
was confirmed in rats by D'Argent, Viallier, an*i
Guinet (27).
Bielshowsky and Hall (28) inhibited the de-
velopment of experimental hepatoma by thyroid-
ectomy in rats (28), while Paschkis promoted
the development by thiouracil (29). Sarcoma
development in response to methyicholanthrene
injections was slowed down in thyroidectomized
rats (Wolfson, Drake, and Bass (30)).
Finally it appears worthy of note that a number
of different investigators failed to observe any
influence of thyroidectomy on experimental
tumor growth or on transplantability of tumors in
experimental animals (Morimoto (31), Bischoff
and Maxwell (32), Smith, el al (33) and Sloviter
(34)).
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The present experiments were devised in an
attempt to gain information on the question
whether or not tri-iodothyronine does influence
the incidence of chemically induced epidcrmal
tumor formation; and whether or not such an
influence may result from alteration of the hair
cycle by the hormone.
METHODS AND MATERIALS
General Design of Experiment
Mice were subjected to a single exposure of a
potent carcinogen, either during the growing—
or during the resting phase of the hair cycle.
During the same periods the animals received
liothyronine by injection or by feeding, while
parallel groups which did not receive the hormone
were used as controls.
The time of exposure to the carcinogen during
the resting phase (which may last about a month),
as well as the period of liothyronine administra-
tion (prior to the exposure) were varied in several
series of the experiment.
Animals. Swiss Albino mice bred in our labora-
tory.
Carcinogen. Delivery of 0.05 ml of a 0.5% solu-
tion of 9,10 - dimethyl - 1,2 - benzanthracene*(DMBA) to the skin surface of the interscapular
area.
Agent Employed to Potentiate Thyroid Function.
a) L-triiodothyronine sodium or liothyronine
sodium (Cytomel) powdert dissolved in distilled
water to contain 6 mcgm (Mg) per 0.25 ml.; this
volume was inj ected subcutaneously 5 times a
week (experimental groups A-i, 5, BI-i, BIT-i).
b) One tablet containing 5 mcgm. liothyronine
sodium was taken up in 0.5 ml. water and adminis-
tered by means of a stomach tube 5 times weekly
(group A-3).
Hair Dye. "Roux", a commercial paraphenyl-
ene-diamine product of the darkest shade avail-
able.
Recognition of Phase of Hair Cycle (by means of
Borum's method (35)). The fur on the back of all
mice was dyed at the age of 28 days. This was
repeated after the growth period (anagen) of the
2nd hair cycle—or pelage—was terminated; and
again after the growing phase of the 3rd hair
cycle. Growth of a new hair generation was recog-
nized from the emergence of white hair on the
surface. The end of the growing phase, viz., the
beginning of the resting phase (telogen) was
recognized from a uniform greyish color of the
dorsal fur, which did not change any further.
Experimental Series A. Group 1—("Abbre-
viated telogen"): Carcinogen exposure at the time
of early natural telogen, in combination with
liothyronine injections aimed at induction of
premature anagen: In 74 male, and in 75 female
mice a single exposure to DMBA was performed
one week after the termination of the second
anagen period. The liothyronine injections were
started one week prior to the DMBA exposure.
Group 2—("Natural telogen"—lst control
group): Carcinogen exposure during early telogen,
without liothyronine injections: Sixty male and
sixty female mice were exposed once to DMBA
as described for group 1, but "hormone" injections
were omitted. The carcinogen, therefore, was
applied during the period of natural hair follicular
rest.
Group 3—("Abbreviated telogen"): Thirty-
seven males and twenty-nine females were sub-jected to the same procedure as was group i,
but feeding of liothyronine tablets replaced the
injections of the "hormone".
Group 4—("Natural telogen"—2nd control
group): Twenty-eight males and thirty-seven
female animals were exposed to DMBA like the
animals of groups 1 and 3, but "hormone" ad-
ministration was omitted.
Group 5— ("Abbreviated telogen' '—anagen ex-
periment): Liothyronine was injected in forty-
nine male mice and in thirty-six females; the in-
jections were started on the 24—26th day of life,
i.e., shortly prior to the time of natural termina-
tion of the first resting phase—and were con-
tinued throughout the experiment; the carcinogen
was applied one week after start of the injections.
Group 6—("Natural anagen"—eontrol group):
A single exposure to DMBA in 30 male and in 50
female mice was performed during the growing
phase (i.e., at the day of emergence of the second
pelage above the skin surface). No liothyronine
injections.
The experiment was terminated three months
after the carcinogen application.
Fifty-six additional mice, rather evenly dis-
tributed among the six groups, were used for ob-
serving the effect of liothyronine only on the
hair cycle, without the exposure to DMBA.
Experimental Series B (exposure at later time
of telogen). Subseries I. Group 1—("Induced
anagen"): A single exposure to DMBA was em-
ployed in 49 male and in 33 female animals three
weeks after the anagen period of the 2nd hair
cycle was terminated.
Liothyronine injections were started one week
prior to the DMBA application and continued
throughout the experiment.
Group 2—("Natural telogen"—lst control
group): Carcinogen exposure in 41 male and in 28
female animals as in group 1, but liothyronine
injections were omitted.
Subseries II. Group 1—Thirty-one male and
fifty-one female mice were exposed to DMBA
in the same manner as were the mice of group 1 of
the preceding subseries; but the liothyronine
* Obtained from Eastman Organic Chemicals.
f We are indebted to the manufacturers, Smith
Kline & French, Philadelphia, for supplying us
with this material and for their kind cooperation.
HAIR CYCLE AND CARCINOGENESIS IN MICE 227
TABLE I
No. of days of resting phase (telogen) of second hair cycle
Range, Quartiles, and Median
telogen duration in the controls.
Italics: P < 0.05.
Boldface: P < 0.01.
injections were started three weeks (rather than
one week) prior to the DMBA application.
Group 2—(2nd control group): Twenty-eight
male and forty-seven female animals received the
DMBA painting exactly as the animals of group
1, but liothyronine was not injected.
In order to exclude the possibility that the fur-
dyeing per se may cause precocious growth of hair,
the following test procedure preceded the actual
experiments:
The fur of the back of 13 male and 20 female
mice was dyed black at the 28th day of life, i.e.,
after growth of the first hair generation was com-
pleted. The hair of the second hair generation was
then allowed to grow out. One week after this
second anagen period had ended and the fur had
assumed a uniformly silver gray color, the dorsal
hair on the left side of the midline of the back was
again dyed black, while the right side served as
control. On this control side the growth of the
third hair generation was recognized from the
lighter gray of the fur after the new (third) hair
generation had emerged, whereas on the left side
the black color changed to a much darker gray
at the comparable phase of growth. It was found
that in all 33 mice the hair of the third pelage
emerged at the same time on both sides of the
median line and that on both sides the hair growth
progressed at the same rate, being completed on
either side precisely at the same time. Hence it
was evident that dyeing of the resting hair of the
second pelage did not affect the growth of the
succeeding hair generation.
EXPERIMENTAL RESULTS*
Effect of 1-3-iodothyronine (Liothyronine)
Administration on Hair Growth
The influence of iodothyronine on hair growth
observed in the different groups of experimental
series A is shown in Tables I and II. Actually, in
essence this influence was found to be demon-
strable by a number of different computations.
Among these, the following were chosen for this
presentation: The length of the resting phase
* Statistical consultant, Dr. R. R. Freudenthal,
Jackson Heights, N. Y.
Male Mice Female Mice
Groups 1RI
2
C
3
RF
4
C
5
GI
6
C
1
RI
2
C
3
RF
4
C
5
GI
6
C
Number of Mice
Low
1st Quartile
Median
3rd Quartile
High
78
7
18
24
28
48
61
6
20
26
40
84
41
14
26
28
40
52
29
18
34
36
42
103
60
8
18
22
34
64
30
8
22
28
34
67
91
8
16
22
24
55
67
8
22
32
42
64
34
14
18
22
32
50
34
12
28
36
42
63
40
7
18
20
24
54
54
10
22
28
36
54
Key:
Low = No. of days of second telogen, after which 1st mouse began growth of 3rd anagen.
High = No. of days of second telogen, after which last mouse began growth of 3rd anagen.
1st Quartile = No. of days of second telogen, after which at least 25% of the mice had begun 3rd
al1agefl.
Median = No. of days of second telogen, after which 50% of the mice had begun 3rd anagen.
3rd Quartile = No. of days of second telogen, after which at least 25% of the mice have not yet
begun 3rd anagen.
R—DMBA at time of natural telogen.
G—DMBA at time of natural anagen.
1—liodothyronine by injection.
F—liodothyronine by feeding.
C—Controls (No liothyronine).
Figures in italics and in boldface (no. of days) indicate that differences are significant: For 1st quar-
tile and median the abbreviation of telogen as compared with the controls; for 3rd quartile the longer
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(telogen) of the second pelage, i.e., the interval
between the second and third growing phase
(anagen) observed in each group (Table I);
and the age of the animals of all groups at the
time of termination of the third anagen (Table
II).
Tables I and II show the ranges of the length
of the 2nd telogen and those of the age at the end
of the third anagen, respectively, in number of
days for the different groups. Table I furthermore
shows the maximum number of 2nd telogen days
after which one quarter or more of all animals in a
group (1st quartile) had started the 3rd growing
phase (anagen), as well as the number of 2nd
telogen days after which half the number of
animals per group (median) had started the 3rd
anagen phase; and likewise the number of 2nd
telogen days after which one quarter or more of
all animals per group (3rd quartile) had failed to
manifest any signs of growth of the 3rd hair
generation. Table II shows the corresponding
data for the age of the mice in the different groups
at the time of termination of the 3rd anagen
phase.
Values in italics listed in Table I for the 1st
quartile of the liothyronine groups indicate that
there is a significant difference between the data
ascertained in the 25% or more mice which had
already started (or completed) their 3rd growing
phase and the data ascertained in the fewer, if
any, of the controls which had started (or com-
pleted) this phase. Similarly, values in boldface
for the third quartile of the control mice indicate
a significant difference between the observations
recorded for the 25% or more of the control mice
and those recorded for the smaller quotas of the
liothyronine mice which have not yet started
(or completed) the 3rd anagen at that time.
Italic denotes P < 0.05; boldface denotes
P < 0.01.
These compilations (Tables I and II) do not
leave any doubt that the administration of
triodothyronine tends to cause a precocious onset
of hair growth in mice. The difference, as com-
pared with the onset of the respective growing
phases in the control animals, was significant in
most of the experimental groups.
Regarding the relation in time of the carcino-
gen exposure of the animals' skin to the hair
cycle, the "antedating" effect of liothyronine on
subsequent hair growth was most apparent in
our experimental series B, where the exposure
was performed late during telogen of the second
pelage, i.e., three weeks after the second anagen
was completed. There was a relatively consider-
able number of instances, in which the DMBA
Age of mice at end of
TABLE II
growing phase (anegen) of third hair cycle (in days)
Male Mice Female Mice
Geoups 1
RI
2
C
3
RF
4
C
5
GI
5
C
1
RI
2
C
3
RF
4
C
5
GI
5
C
Number of Mice
Low
1st Quartile
Median
3rd Quartile
High
75
50
80
85
95
58
75
85
95
110
36
75
85
90
115
27
85
105
110
140
47
45
75
85
105
125
27
70
85
95
110
90
65
75
80
85
115
66
75
85
100
115
32
70
75
85
95
130
33
75
90
100
105
130
34
70
75
80
85
105
48
70
80
90
110
Key:
Low = Age (No. of days) at which 1st mouse ended 3rd anagen. Ran eHigh = Age (No. of days) at which last mouse ended 3rd anagen.J g
1st Quartile = Age (No. of days) at which at least 25% of the mice had terminated 3rd anagen.
Median = Age (No. of days) at which at least 50% of the mice terminated 3rd anagen.
3rd Quartile = Age (No. of days) at which at least 25% of the control mice have not yet terminated
3rd anagen.
Figures in italics and in boldface (no. of days—ages at termination of 3rd anagen) indicate signifi-
cant differences between the ages in experimental and control groups.
Italics: P < 0.05.
Boldface: P < 0.01.
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DMBA 1 week after completion of
2nd growing phase. Liothyronine
injections started 1 week before
DMBA exposure
DMBA as in group 1, but no ho-
thyronine injections
DMBA as in group 1. Liothyronine
fed by tube
DMBA as in group 1, but no ho-
thyronine
DMBA at time of natural growing
phase. Liothyronine injections
started 1 week earlier
DMBA as in group 5, but no liothy-
ronine injections
application occurred actually after the third
growing phase had begun, at a time when or-
dinarily the hair follicles were still due to be at
rest. This premature onset of hair growth was
more pronounced in the female than in the male
mice—and was most pronounced in the animals
in which hiothyronine had been administered
three weeks (rather than one week) prior to the
exposure to DMBA.
Effect of Liothyronine Administration on Tumor
Incidence
The incidence of epidermal tumor formation
observed in our experimental series A is shown
in Table III, that observed in series B is shown
on Table IV. *
Series A: At a first glance, the percentage
number of tumor bearers appears to be somewhat
higher in most of the control groups than in
the corresponding experimental (liothyronine)
groups. This difference, however, is not signifi-
cant.
It is, moreover, evident from Table III that the
tumor incidence obtained in the groups exposed
to DMBA at the time of natural telogen definitely
exceeded that obtained in the corresponding
groups exposed to DMBA during natural anagen.
In addition, the tumor incidence was in this
series considerably higher in the female animals
exposed to the carcinogen at the time when natural
hair follicular rest was due than in the male ani-
mals of the corresponding groups; but this differ-
ence shows statistical significance in the control
groups only.
Series B: (Table IV) Except for the findings
obtained in the male mice of group 1 in subseries
I, no difference was observed in the tumor in-
cidence in any of the experimental (liothyronine-)
and corresponding control groups. The male
group I, 1, in which the liothyronine injections
were started one week prior to the DMBA ex-
posure, i.e., two weeks after termination of the
second anagen period, showed a higher per-
centage of tumor bearers than did the control
groups; but this difference falls short of statistical
significance.
DISCUSSION
Hair Growth
In agreement with the observations of Chang
(15) and of Baker (7) that the absence of thyroid
hormone causes inhibition of normal hair growth
TABLE III
Incidence of epidermal tumors in mice exposed to DMBA once during either phase of
the hair cycle with or without concomitant liothyronine administration
(Experimental series A)
Group
Male Mice Female Mice
1
2
3
4
5
6
Number of
mice alive 30
days after
exposure to
DMBA
74
60
37
27
49
30
Number
of tumor
bearers
19
15
9
10
3
3
Per cent
25
25
24
37
6
10
Number of
mice alive 30
days after
exposure to
DMBA
75
60
29
33
36
50
Number
of tumor
bearers
29
28
10
19
1
3
Per cent
39
47
34
58
3
6
* Neither in series A nor in series B was there
any difference between the mean weights of the
animals in the liothyronine-and the corresponding
control groups.
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TABLE IV
Number of tumor bearers in mice exposed to DMBA 3 weeks after completion of growth of
2nd hair generation
(Experimental series B)
Group Experimental Design
Male Mice Female Mice
Number of
mice alive 4
weeks after
exposure to
DMBA
Number
of tumor
bearers
Per cent
Number of
mice alive 4
weeks after
exposure toDMBA
Number
uf tumor
bearers
Per cent
Subseries I
1
2
Liothyronine injection started 1
week prior to DMBA
Control, no liothyronine
47
40
12
3
26
7
31
28
1
5
3
8
Subseries II
1
2
Liothyronine injection started 2
weeks prior to DMBA
Control, no liothyronine
30
27
4
4
7
7
51
47
5
4
10
12
in rats, as well as in agreement with the observa-
tions of Butcher (16, 17), Mohn (18) and others,
that thyroxin produces stimulation of hair growth
in rats, liothyronine administered under our
experimental conditions in mice induced a
distinct promotion of hair growth. This promo-
tion, in most instances was characterized both
by acceleration of the normal growth wave
(Table II) and by abbreviation of the normal
resting phase (Table I). This effect was more
pronounced in the female animals, in which
individual hair cycles normally succeed at a
somewhat slower and less regular rate than in the
male animals. Liothyronine medication tended
to abolish this sex difference.
As it takes about 11 days from the beginning
of early anagen to the emergence of the new hair
above the skin surface (Chase et al (36), Morrill
et al (6)), the fur of the mice in which the interval
between carcinogenic exposure and the appear-
ance of new hair was shorter than 11 days was
actually in early anagen at the time of DMBA
application.
Even without any liothyronine administra-
tion, there were in most of our (control-) groups
a few mice which, for some unknown (intrinsic?)
reason, on the basis of this evidence manifested
hair growth unexpectedly soon after completion
of the preceding anagen.
In the liothyroninc injected groups, however,
the number of animals showing premature con-
version of telogcn into anagen was distinctly
greater than in the control groups. This difference
was statistically significant for the female groups
of our experimental series A, in which DMBA
was applied one week after completion of the
second growing phase, and for nearly all groups
of experimental series B, in which the carcinogen
was applied three weeks after completion of the
second growing phase.
In a substantial number of animals the new
hair emerged already above the skin surface even
prior to—or just on the day of—the carcinogen
application (thus shifting the time of application
into a somewhat later period of the growing
phase).
Tumor Incidence
In spite of the conversion of the telogen period
into anagen attained by our "hormone" adminis-
tration—and quite contrary to our expectations,
tumor development was not reduced in any of the
liothyronine groups.
Whereas it was anticipated that liothyronine
administration would not alter the tumor inci-
dence in the animals in which the carcinogen was
applied during the growing phase (group A-5)
and similarly, that no difference in the incidence
would occur in animals exposed to DMBA at
the time of natural hair follicular rest, but failing
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to show any indication of a conversion of telogen
into anagen at that time (as was the case in the
male animals of groups A-i, and A-3), a reduction
in the tumor incidence would have been expected
in all of those groups where the resting phase
had been converted into the growing phase at the
time of exposure to the carcinogen; i.e., in the
experimental female groups of A-i and A-3, and
in the male and female groups of both B-I and
B-Il (exposed to DMBA three weeks after the
second telogcn began).
As is apparent from Table IV, the overall tumor
incidence was rather low throughout the groups of
series B. This is explained by the fact that the fur
of a relatively large number of mice—to some
extent even in the control groups—was at hair
follicular growth at the time of the carcinogen
application.
The application nevertheless quite generally
occurred during the growing phase in many more
mice of our liothyronine- than of our control
groups. Yet, none of the control groups showed a
higher tumor incidence. Actually tumors occurred
more frequently in the liothyronine treated males
of group B, Subseries I. This apparently is at
variance with any prediction that may have been
made on the basis of the reports by Borum,
Andreasen, and Englebreth-llolm (12, 14), or
on the basis of our own (1—4) and other published
observations (5).
While this increase did not quite reach statisti-
cal significance, it seemed to suggest the possi-
bility that a factor promoting tumor development
might be associated with the administration of
liothyronine, which may largely be "neutralized"
and masked by the protective influence of hair
follicular growth activity ("hair cycle-effect").
It would, therefore, appear of interest to investi-
gate the effect of liothyronine on experimental
skin earcinogenesis under conditions eliminating
or counteracting this hair cycle effect as far as
possible.
SUMMARY
1. The effect of liothyronine administration on
the hair cycle and on chemically induced epider-
mal careinogenesis was investigated in mice.
Experiments were designed in a manner which
would permit the study of the action of this
preparation on the hair cycle and to study the
relationship—if any—between the effect of the
preparation on hair growth and its effect on
tumor development.
The phases of the hair cycle were ascertained
by means of dyeing the fur, according to the
technic introduced by Borum (35).
2. Definite stimulation of hair growth was
observed in all groups of animals which had
received liothyronine.
3. No decrease in the tumor incidence was
obtained under the influence of liothyronine
administration. Indeed under certain experimen-
tal conditions an unexpected increase occurred
after the administration.
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